Automated breast ultrasound system is used to obtain ultrasound images using a transducer that scans the whole breast and provides three-dimensional (3D) images for cancer detection in dense breast tissues. Automated breast ultrasound examination offers benefits such as less turnaround time, 3D images and coronal view, among others, ensuring improved diagnostic confidence.
Various clinical trials are underway to provide recognition to automated breast ultrasound or whole breast ultrasound imaging for detection of cancer for women with dense breasts.
Market Value and Forecast
In terms of value, the global automated breast ultrasound system market size is anticipated to expand at a CAGR of 8.1% during the forecast period. Moreover, global ABUS market installations are expected to increase to 1,013 units by 2025 end.
Growth of the global automated breast ultrasound system market is mainly driven by rising health awareness, government advocation for breast cancer awareness, extensive research and development for enhanced imaging techniques for cancer detection, increasing prevalence of breast cancer and growing radiology market.
However, lack of ABUS adoption as a screening tool, lack of trained personnel and inadequate insurance coverage coupled with high prices of these devices are restraining market growth.
Moreover, shortcomings of other imaging methods such as radiation exposure, high costs of Magnetic Resonance Imaging (MRI) and inefficiency of mammography in detection of cancer in women with dense breasts, thus elevating breast cancer risks, are anticipated to drive demand for advanced screening systems such as ABUS.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Segmentation by End User
The global automated breast ultrasound system market is segmented on the basis of end user into hospitals and diagnostic imaging laboratories. In terms of value, the hospitals segment is estimated to account for over 55% share in the global ABUS market share by 2015 end and is expected to remain dominant during the forecast period.
The global automated breast ultrasound system market analysis has been segmented into seven major regions, namely, North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan (APEJ), Japan, and Middle East & Africa. In terms of value, North America is estimated to dominate the market with 46.1% share in the overall ABUS market by 2015 end.
Also, Japan is anticipated to be the fastest growing market, registering a CAGR of 9.9% in terms of value and volume in the automated breast ultrasound system market over the forecast period.
Some key players identified in the global automated breast ultrasound system market include GE Electric Co., Siemens A.G., Hitachi Ltd., SonoCiné Inc. These players are focused on expanding their global presence through increasing installation of ABUS in hospitals and diagnostic imaging laboratories.
Key Segments Covered
By End User
- Diagnostic Imaging Laboratories
Key Regions covered:
- North America
- Latin America
- Rest of Latin America
- Western Europe
- BENELUX (Belgium, Netherlands, Luxembourg)
- NORDIC (Denmark, Finland, Iceland, Norway, Sweden)
- Rest of Europe
- Eastern Europe
- Rest of Eastern Europe
- APEJ (Asia Pacific excluding Japan)
- ASEAN Countries
- Australia & New Zealand
- Rest of APEJ
- GCC Countries
- South Africa
- Rest of Middle East & Africa